Bio Path Holdings, Inc. financial data

Symbol
BPTH on OTC
Location
4710 Bellaire Boulevard, Suite 210, Bellaire, TX
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2025 - Aug 14, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 49.2 % -65.8%
Debt-to-equity -195 % -124%
Return On Equity 478 %
Return On Assets -503 % -64.1%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 8.31M shares +226%
Common Stock, Shares, Outstanding 8.31M shares +264%
Entity Public Float 5.04M USD -62.7%
Common Stock, Value, Issued 8K USD +300%
Weighted Average Number of Shares Outstanding, Basic 8.31M shares +415%
Weighted Average Number of Shares Outstanding, Diluted 8.31M shares +415%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 9.16M USD +4.93%
General and Administrative Expense 3.9M USD -9.51%
Operating Income (Loss) -13.1M USD -0.15%
Nonoperating Income (Expense) 745K USD -48.4%
Net Income (Loss) Attributable to Parent -12.3M USD -6.21%
Earnings Per Share, Basic 0 USD/shares +52.6%
Earnings Per Share, Diluted 0 USD/shares +52.6%

Balance Sheet

Label TTM Value / Value Unit Change %
Other Assets, Current 206K USD -72.1%
Assets, Current 680K USD -86.5%
Property, Plant and Equipment, Net 9K USD -81.3%
Operating Lease, Right-of-Use Asset 57K USD +11.8%
Assets 746K USD -85.4%
Accounts Payable, Current 3.48M USD +354%
Accrued Liabilities, Current 3.91M USD +78.4%
Liabilities, Current 7.86M USD +161%
Operating Lease, Liability, Noncurrent 3K USD -96.5%
Liabilities 7.9M USD +107%
Retained Earnings (Accumulated Deficit) -125M USD -10.9%
Stockholders' Equity Attributable to Parent -7.16M USD -654%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest -7.16M USD -654%
Liabilities and Equity 746K USD -85.4%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -1.31M USD -26.5%
Net Cash Provided by (Used in) Financing Activities 262K USD +50.6%
Common Stock, Shares Authorized 200M shares 0%
Common Stock, Shares, Issued 8.31M shares +264%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -1.05M USD -21.6%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 0 USD -100%
Deferred Tax Assets, Valuation Allowance 27.6M USD +14.3%
Deferred Tax Assets, Gross 27.6M USD +14.3%
Operating Lease, Liability 83K USD -26.5%
Depreciation 2K USD -90.9%
Lessee, Operating Lease, Liability, to be Paid 86K USD -27.7%
Property, Plant and Equipment, Gross 1.01M USD -9.82%
Operating Lease, Liability, Current 57K USD +3.64%
Lessee, Operating Lease, Liability, to be Paid, Year Two 11K USD -89.8%
Lessee, Operating Lease, Liability, to be Paid, Year One 86K USD -20.4%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 3K USD -50%
Deferred Tax Assets, Operating Loss Carryforwards 19.3M USD +3.84%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 0 USD
Additional Paid in Capital 118M USD +3.39%
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance 17K USD -19%
Share-based Payment Arrangement, Expense 900K USD 0%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%